209 related articles for article (PubMed ID: 7075646)
1. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
Siber GR; Gorham CC; Ericson JF; Smith AL
Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
Halstenson CE; Blevins RB; Salem NG; Matzke GR
Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
Nissenson AR; Wilson C; Holazo A
Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
Martea M; Hekster YA; Vree TB; Voets AJ; Berden JH
Pharm Weekbl Sci; 1987 Apr; 9(2):110-6. PubMed ID: 3495778
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
Rieder VJ; Schwartz DE
Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
Brown MP; Gronwall R; Castro L
Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis ].
de Fremont JF; Schmit JL; Thomas D; Coevoet B; Eb F; Laurence G; Orfila J; Fournier A
Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):581-4. PubMed ID: 6750528
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tolerance of a single twelve-tablet dose of trimethoprim (960 mg)-sulfamethoxazole (4,800 mg).
Fass RJ; Prior RB; Perkins RL
Antimicrob Agents Chemother; 1977 Jul; 12(1):102-6. PubMed ID: 883811
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderly.
Varoquaux O; Lajoie D; Gobert C; Cordonnier P; Ducreuzet C; Pays M; Advenier C
Br J Clin Pharmacol; 1985 Dec; 20(6):575-81. PubMed ID: 3879182
[TBL] [Abstract][Full Text] [Related]
11. [Co-trimoxazole concentration in the prostatic fluid of patients with subacute and chronic prostatitis].
Hofstetter A; Friesen A; Bishop-Freudling GB; Vergin H
Fortschr Med; 1984 Mar; 102(9):244-6. PubMed ID: 6608482
[TBL] [Abstract][Full Text] [Related]
12. Intrarenal distribution of trimethoprim and sulfamethoxazole.
Trottier S; Bergeron MG; Lessard C
Antimicrob Agents Chemother; 1980 Mar; 17(3):383-8. PubMed ID: 7425603
[TBL] [Abstract][Full Text] [Related]
13. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
Grossman PL; Remington JS
Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
[TBL] [Abstract][Full Text] [Related]
15. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
Overturf GD
Rev Infect Dis; 1987; 9 Suppl 2():S168-76. PubMed ID: 3554455
[TBL] [Abstract][Full Text] [Related]
16. Treatment of gonorrhea with trimethoprim-sulfamethoxazole.
Elliott WC; Reynolds G; Thornsberry C; Kellogg DS; Jaffe HW; Brown ST; Armstrong J; Rein MF
J Infect Dis; 1977 Jun; 135(6):939-43. PubMed ID: 405433
[TBL] [Abstract][Full Text] [Related]
17. Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis.
Nelson JD; Kusmiesz H; Shelton S
Rev Infect Dis; 1982; 4(2):546-50. PubMed ID: 6981170
[TBL] [Abstract][Full Text] [Related]
18. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
Morel C; Langeard M; Vergnaud M; Monrocq N
Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
Kim KS; Anthony BF
Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
[TBL] [Abstract][Full Text] [Related]
20. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
Hughes DT; Russell NJ
Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
